NCT07008092 Prostaglandin-E Urinary Metabolite (PGE-M) as a Predictor of Acute Appendicitis in Children
| NCT ID | NCT07008092 |
| Status | Recruiting |
| Phase | — |
| Sponsor | KBC Split |
| Condition | Acute Appendicitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-06-02 |
| Primary Completion | 2026-05-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Diagnosing acute appendicitis in children remains a clinical challenge, with delayed or incorrect diagnosis potentially leading to serious complications or unnecessary surgery. Prostaglandin E urinary metabolites (PGE-M) have been found elevated in various inflammatory conditions, but their diagnostic value in pediatric appendicitis is not well established. This study aims to assess the potential of PGE-M as a biomarker for acute appendicitis in children. The study will be conducted over 12 months and will include 100 children aged 5 to 17 years presenting with acute abdominal pain. In addition to routine laboratory tests, urinary PGE-M levels will be analyzed. The study involves minimal risk to participants
Eligibility Criteria
Inclusion Criteria: * children of age 5 -17 years with acute abdominal pain * children with clinical signs of acute appendicitis Exclusion Criteria: * previous diagnosis of chronic and/or malignant disease * children who had previous abdominal surgery * pregnancy